microDAO.bio
Sign up to join the beta testing of our Pathogen Catalogue.
The rollout will occur in batches, with the first cohort expected to begin in mid-to-late January 2026.
Link: catalogue.microdao.bio/beta
Industrial and corporate activities play a critical and often overlooked role in accelerating resistance especially through untreated industrial effluents and pharmaceutical wastes.
link: shorturl.at/EIOQF
Industrial and corporate activities play a critical and often overlooked role in accelerating resistance especially through untreated industrial effluents and pharmaceutical wastes.
link: shorturl.at/EIOQF
Antimicrobial resistance doesn’t start in hospitals alone, it often begins with preventable infections in everyday life.
Practicing good hygiene like regular handwashing and proper sanitation reduces the spread of infectious agents.
Antimicrobial resistance doesn’t start in hospitals alone, it often begins with preventable infections in everyday life.
Practicing good hygiene like regular handwashing and proper sanitation reduces the spread of infectious agents.
Rising temperatures help bacteria grow faster and share resistance genes, creating ideal conditions for antimicrobial resistance (AMR) to spread.
Rising temperatures help bacteria grow faster and share resistance genes, creating ideal conditions for antimicrobial resistance (AMR) to spread.
It starts with everyday habits.
Clean hands, safe food, fresh air, vaccinations, and staying home when sick reduce infections and the need for antimicrobials slowing antimicrobial resistance.
Small actions. Real protection.
It starts with everyday habits.
Clean hands, safe food, fresh air, vaccinations, and staying home when sick reduce infections and the need for antimicrobials slowing antimicrobial resistance.
Small actions. Real protection.
Fungi are evolving too.
🦠 Candida auris is a multidrug-resistant fungal superbug spreading in hospitals worldwide. It survives on surfaces, targets vulnerable patients, and some strains resist all major antifungal drugs...
Fungi are evolving too.
🦠 Candida auris is a multidrug-resistant fungal superbug spreading in hospitals worldwide. It survives on surfaces, targets vulnerable patients, and some strains resist all major antifungal drugs...
As we enter 2026, we do so with clarity and conviction.
The past year wasn’t about loud wins, it was about laying foundations and building infrastructure that can last.
AMR isn’t a short-term crisis; it’s a structural one.
As we enter 2026, we do so with clarity and conviction.
The past year wasn’t about loud wins, it was about laying foundations and building infrastructure that can last.
AMR isn’t a short-term crisis; it’s a structural one.
Thank you for building, researching, and shaping the future of decentralized science with us.
Here’s to a purposeful year's end.
Thank you for building, researching, and shaping the future of decentralized science with us.
Here’s to a purposeful year's end.
This Christmas, as we embrace celebration and connection, let’s also commit to responsible antibiotic use.
Say yes to festivity, and No to Antimicrobial Resistance (AMR).
This Christmas, as we embrace celebration and connection, let’s also commit to responsible antibiotic use.
Say yes to festivity, and No to Antimicrobial Resistance (AMR).
Tests to detect resistance are not available at time of treatment.
Tests to detect resistance are not available at time of treatment.
Closed beta opens Mid-Jan 2026.
Substack Link→ [https://shorturl.at/07gLH ]
Closed beta opens Mid-Jan 2026.
Substack Link→ [https://shorturl.at/07gLH ]
These microbes are responsible for many of the world’s hardest-to-treat infections.
These microbes are responsible for many of the world’s hardest-to-treat infections.
These multidrug or pan-drug-resistant bacteria and fungi are rising globally, affecting hospitals, communities, and everyday health.
These multidrug or pan-drug-resistant bacteria and fungi are rising globally, affecting hospitals, communities, and everyday health.
Sign up to join the beta testing of our Pathogen Catalogue.
The rollout will occur in batches, with the first cohort expected to begin in mid-to-late January 2026.
Link: catalogue.microdao.bio/beta
Sign up to join the beta testing of our Pathogen Catalogue.
The rollout will occur in batches, with the first cohort expected to begin in mid-to-late January 2026.
Link: catalogue.microdao.bio/beta
Learn about @join_microDAO, Traditional Markets failure to tackle AMR and MicroDAO"s solution
Learn about @join_microDAO, Traditional Markets failure to tackle AMR and MicroDAO"s solution
1/3 World AMR Awareness Week has just ended; A global reminder that antimicrobial resistance isn’t abstract or distant, but a structural challenge already shaping the future of health.
This year showed us something powerful:
1/3 World AMR Awareness Week has just ended; A global reminder that antimicrobial resistance isn’t abstract or distant, but a structural challenge already shaping the future of health.
This year showed us something powerful:
@join_MicroDAO remains committed to building open, collaborative, and decentralised solutions to keep life-saving medicines effective.
@join_MicroDAO remains committed to building open, collaborative, and decentralised solutions to keep life-saving medicines effective.
What happens when medicines that are supposed to treat infections fail to do so?
This is the reality of AMR
What happens when medicines that are supposed to treat infections fail to do so?
This is the reality of AMR
www.youtube.com/live/yZVonSg...
www.youtube.com/live/yZVonSg...
He drives awareness and adoption of Web3 tools that empower scientists, foster collaboration, and accelerate open innovation.
🔗 Register: luma.com/nlwcntc5
He drives awareness and adoption of Web3 tools that empower scientists, foster collaboration, and accelerate open innovation.
🔗 Register: luma.com/nlwcntc5
🔗 Register: luma.com/nlwcntc5
🔗 Register: luma.com/nlwcntc5
A life science product specialist merging microbial signaling research, DIYbio community-building, and DAO structures to drive innovation against AMR.
Link: luma.com/nlwcntc5
A life science product specialist merging microbial signaling research, DIYbio community-building, and DAO structures to drive innovation against AMR.
Link: luma.com/nlwcntc5
He co-invented Enmetazobactam at Orchid Pharma—the first molecule from India to achieve global approval and has led efforts across global health organizations.
Register: luma.com/nlwcntc5
He co-invented Enmetazobactam at Orchid Pharma—the first molecule from India to achieve global approval and has led efforts across global health organizations.
Register: luma.com/nlwcntc5
“Together, we Go Blue to protect our present and secure the future of #DeSci.”
We’re building this movement together.
Join the campaign: t.me/microdao/
“Together, we Go Blue to protect our present and secure the future of #DeSci.”
We’re building this movement together.
Join the campaign: t.me/microdao/